Global Infertility Treatment

Infertility Treatment Comprehensive Study by Application (Fertility Centers, Hospitals and Surgical Clinics, Research Institutes, Cryobanks), Equipment (Microscopes, Imaging Systems, Incubators, Sperm Analyzer Systems, Laser Systems, Micromanipulator Systems, Cryosystems), Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, Other Infertility Treatment Procedures), Patients (Female, Male) Players and Region - Global Market Outlook to 2030

Infertility Treatment Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Infertility Treatment
Infertility is defined as not getting pregnant after 1 year of having regular sexual intercourse without using birth control. The most common cause of infertility in females is a problem with ovulation and in males with sperm cells and how they function. Infertility Treatment market is expected to grow due to factors that affect fertility include age, lifestyle and health conditions. Advancement in technologies to treat infertility among both men and women boosting the infertility treatment market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Infertility Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

The Cooper Companies Inc. (United States), Vitrolife AB (Sweden), Cook Group Incorporated (United States), Esco Micro Pte. Ltd. (Singapore), Thermo Fisher Scientific, Inc. (United States), Genea Limited (Australia), Irvine Scientific (United States), The Baker Company, Inc.(United States), IVFtech ApS (Denmark) and Kitazato (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Rocket Medical Plc (United Kingdom), IHMedical A/S (Denmark), MedGyn Products, Inc. (United States), ZEISS Group (Germany), Hamilton Throne Ltd. (United States) and SoMATEX Medical Technologies GmbH (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Infertility Treatment market by , Application (Fertility Centers, Hospitals and Surgical Clinics, Research Institutes and Cryobanks) and Region.



On the basis of geography, the market of Infertility Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Equipment, the sub-segment i.e. Microscopes will boost the Infertility Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Procedure, the sub-segment i.e. Assisted Reproductive Technology will boost the Infertility Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Patients, the sub-segment i.e. Female will boost the Infertility Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
Rising Number of Fertility Clinics in Developing Countries and Technological Advancements in Infertility Treatment Devices

Challenges:
The High Cost of Procedures

Restraints:
Stringent Government Regulations and Lack of Medical Infrastructure in Underdeveloped Countries

Opportunities:
Growth in Healthcare Infrastructure in Emerging Markets and Demand for Fertility Treatment Options By Same-Sex Couples

Market Leaders and their expansionary development strategies
In November 2021, CooperCompanies (NYSE: COO) has signed a agreement to acquire Generate Life Sciences, a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue).
August 2021: Merck Specialties Pvt ltd, the healthcare business of Merck in India, has launched Pergoveris® Pen for advanced infertility treatment in India. This launch emphasizes the company’s motive of fulfilling unmet medical needs by providing an improved, convenient, and ready-to-use combination treatment option for women with a severe follicle-stimulating hormone (FSH) and and luteinizing hormone (LH) deficiency.


Key Target Audience
Infertility Treatment Device Manufacturers, Medical Device Suppliers and Distributors, Healthcare Service Providers and Research Laboratories

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Fertility Centers
  • Hospitals and Surgical Clinics
  • Research Institutes
  • Cryobanks
By Equipment
  • Microscopes
  • Imaging Systems
  • Incubators
  • Sperm Analyzer Systems
  • Laser Systems
  • Micromanipulator Systems
  • Cryosystems

By Procedure
  • Assisted Reproductive Technology
  • Artificial Insemination
  • Fertility Surgery
  • Other Infertility Treatment Procedures

By Patients
  • Female
  • Male

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Number of Fertility Clinics in Developing Countries
      • 3.2.2. Technological Advancements in Infertility Treatment Devices
    • 3.3. Market Challenges
      • 3.3.1. The High Cost of Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Infertility Treatment, by Application, Equipment, Procedure, Patients and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Infertility Treatment (Value)
      • 5.2.1. Global Infertility Treatment by: Application (Value)
        • 5.2.1.1. Fertility Centers
        • 5.2.1.2. Hospitals and Surgical Clinics
        • 5.2.1.3. Research Institutes
        • 5.2.1.4. Cryobanks
      • 5.2.2. Global Infertility Treatment by: Equipment (Value)
        • 5.2.2.1. Microscopes
        • 5.2.2.2. Imaging Systems
        • 5.2.2.3. Incubators
        • 5.2.2.4. Sperm Analyzer Systems
        • 5.2.2.5. Laser Systems
        • 5.2.2.6. Micromanipulator Systems
        • 5.2.2.7. Cryosystems
      • 5.2.3. Global Infertility Treatment by: Procedure (Value)
        • 5.2.3.1. Assisted Reproductive Technology
        • 5.2.3.2. Artificial Insemination
        • 5.2.3.3. Fertility Surgery
        • 5.2.3.4. Other Infertility Treatment Procedures
      • 5.2.4. Global Infertility Treatment by: Patients (Value)
        • 5.2.4.1. Female
        • 5.2.4.2. Male
      • 5.2.5. Global Infertility Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Infertility Treatment (Price)
  • 6. Infertility Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. The Cooper Companies Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vitrolife AB (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Group Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Esco Micro Pte. Ltd. (Singapore)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genea Limited (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Irvine Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. The Baker Company, Inc.(United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IVFtech ApS (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Kitazato (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Infertility Treatment Sale, by Application, Equipment, Procedure, Patients and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Infertility Treatment (Value)
      • 7.2.1. Global Infertility Treatment by: Application (Value)
        • 7.2.1.1. Fertility Centers
        • 7.2.1.2. Hospitals and Surgical Clinics
        • 7.2.1.3. Research Institutes
        • 7.2.1.4. Cryobanks
      • 7.2.2. Global Infertility Treatment by: Equipment (Value)
        • 7.2.2.1. Microscopes
        • 7.2.2.2. Imaging Systems
        • 7.2.2.3. Incubators
        • 7.2.2.4. Sperm Analyzer Systems
        • 7.2.2.5. Laser Systems
        • 7.2.2.6. Micromanipulator Systems
        • 7.2.2.7. Cryosystems
      • 7.2.3. Global Infertility Treatment by: Procedure (Value)
        • 7.2.3.1. Assisted Reproductive Technology
        • 7.2.3.2. Artificial Insemination
        • 7.2.3.3. Fertility Surgery
        • 7.2.3.4. Other Infertility Treatment Procedures
      • 7.2.4. Global Infertility Treatment by: Patients (Value)
        • 7.2.4.1. Female
        • 7.2.4.2. Male
      • 7.2.5. Global Infertility Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Infertility Treatment (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Infertility Treatment: by Application(USD Million)
  • Table 2. Infertility Treatment Fertility Centers , by Region USD Million (2018-2023)
  • Table 3. Infertility Treatment Hospitals and Surgical Clinics , by Region USD Million (2018-2023)
  • Table 4. Infertility Treatment Research Institutes , by Region USD Million (2018-2023)
  • Table 5. Infertility Treatment Cryobanks , by Region USD Million (2018-2023)
  • Table 6. Infertility Treatment: by Equipment(USD Million)
  • Table 7. Infertility Treatment Microscopes , by Region USD Million (2018-2023)
  • Table 8. Infertility Treatment Imaging Systems , by Region USD Million (2018-2023)
  • Table 9. Infertility Treatment Incubators , by Region USD Million (2018-2023)
  • Table 10. Infertility Treatment Sperm Analyzer Systems , by Region USD Million (2018-2023)
  • Table 11. Infertility Treatment Laser Systems , by Region USD Million (2018-2023)
  • Table 12. Infertility Treatment Micromanipulator Systems , by Region USD Million (2018-2023)
  • Table 13. Infertility Treatment Cryosystems , by Region USD Million (2018-2023)
  • Table 14. Infertility Treatment: by Procedure(USD Million)
  • Table 15. Infertility Treatment Assisted Reproductive Technology , by Region USD Million (2018-2023)
  • Table 16. Infertility Treatment Artificial Insemination , by Region USD Million (2018-2023)
  • Table 17. Infertility Treatment Fertility Surgery , by Region USD Million (2018-2023)
  • Table 18. Infertility Treatment Other Infertility Treatment Procedures , by Region USD Million (2018-2023)
  • Table 19. Infertility Treatment: by Patients(USD Million)
  • Table 20. Infertility Treatment Female , by Region USD Million (2018-2023)
  • Table 21. Infertility Treatment Male , by Region USD Million (2018-2023)
  • Table 22. South America Infertility Treatment, by Country USD Million (2018-2023)
  • Table 23. South America Infertility Treatment, by Application USD Million (2018-2023)
  • Table 24. South America Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 25. South America Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 26. South America Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 27. Brazil Infertility Treatment, by Application USD Million (2018-2023)
  • Table 28. Brazil Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 29. Brazil Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 30. Brazil Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 31. Argentina Infertility Treatment, by Application USD Million (2018-2023)
  • Table 32. Argentina Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 33. Argentina Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 34. Argentina Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 35. Rest of South America Infertility Treatment, by Application USD Million (2018-2023)
  • Table 36. Rest of South America Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 37. Rest of South America Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 38. Rest of South America Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 39. Asia Pacific Infertility Treatment, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Infertility Treatment, by Application USD Million (2018-2023)
  • Table 41. Asia Pacific Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 42. Asia Pacific Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 43. Asia Pacific Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 44. China Infertility Treatment, by Application USD Million (2018-2023)
  • Table 45. China Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 46. China Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 47. China Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 48. Japan Infertility Treatment, by Application USD Million (2018-2023)
  • Table 49. Japan Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 50. Japan Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 51. Japan Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 52. India Infertility Treatment, by Application USD Million (2018-2023)
  • Table 53. India Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 54. India Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 55. India Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 56. South Korea Infertility Treatment, by Application USD Million (2018-2023)
  • Table 57. South Korea Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 58. South Korea Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 59. South Korea Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 60. Taiwan Infertility Treatment, by Application USD Million (2018-2023)
  • Table 61. Taiwan Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 62. Taiwan Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 63. Taiwan Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 64. Australia Infertility Treatment, by Application USD Million (2018-2023)
  • Table 65. Australia Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 66. Australia Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 67. Australia Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Infertility Treatment, by Application USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 72. Europe Infertility Treatment, by Country USD Million (2018-2023)
  • Table 73. Europe Infertility Treatment, by Application USD Million (2018-2023)
  • Table 74. Europe Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 75. Europe Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 76. Europe Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 77. Germany Infertility Treatment, by Application USD Million (2018-2023)
  • Table 78. Germany Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 79. Germany Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 80. Germany Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 81. France Infertility Treatment, by Application USD Million (2018-2023)
  • Table 82. France Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 83. France Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 84. France Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 85. Italy Infertility Treatment, by Application USD Million (2018-2023)
  • Table 86. Italy Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 87. Italy Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 88. Italy Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 89. United Kingdom Infertility Treatment, by Application USD Million (2018-2023)
  • Table 90. United Kingdom Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 91. United Kingdom Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 92. United Kingdom Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 93. Netherlands Infertility Treatment, by Application USD Million (2018-2023)
  • Table 94. Netherlands Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 95. Netherlands Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 96. Netherlands Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 97. Rest of Europe Infertility Treatment, by Application USD Million (2018-2023)
  • Table 98. Rest of Europe Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 99. Rest of Europe Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 100. Rest of Europe Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 101. MEA Infertility Treatment, by Country USD Million (2018-2023)
  • Table 102. MEA Infertility Treatment, by Application USD Million (2018-2023)
  • Table 103. MEA Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 104. MEA Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 105. MEA Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 106. Middle East Infertility Treatment, by Application USD Million (2018-2023)
  • Table 107. Middle East Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 108. Middle East Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 109. Middle East Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 110. Africa Infertility Treatment, by Application USD Million (2018-2023)
  • Table 111. Africa Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 112. Africa Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 113. Africa Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 114. North America Infertility Treatment, by Country USD Million (2018-2023)
  • Table 115. North America Infertility Treatment, by Application USD Million (2018-2023)
  • Table 116. North America Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 117. North America Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 118. North America Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 119. United States Infertility Treatment, by Application USD Million (2018-2023)
  • Table 120. United States Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 121. United States Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 122. United States Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 123. Canada Infertility Treatment, by Application USD Million (2018-2023)
  • Table 124. Canada Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 125. Canada Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 126. Canada Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 127. Mexico Infertility Treatment, by Application USD Million (2018-2023)
  • Table 128. Mexico Infertility Treatment, by Equipment USD Million (2018-2023)
  • Table 129. Mexico Infertility Treatment, by Procedure USD Million (2018-2023)
  • Table 130. Mexico Infertility Treatment, by Patients USD Million (2018-2023)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Infertility Treatment: by Application(USD Million)
  • Table 142. Infertility Treatment Fertility Centers , by Region USD Million (2025-2030)
  • Table 143. Infertility Treatment Hospitals and Surgical Clinics , by Region USD Million (2025-2030)
  • Table 144. Infertility Treatment Research Institutes , by Region USD Million (2025-2030)
  • Table 145. Infertility Treatment Cryobanks , by Region USD Million (2025-2030)
  • Table 146. Infertility Treatment: by Equipment(USD Million)
  • Table 147. Infertility Treatment Microscopes , by Region USD Million (2025-2030)
  • Table 148. Infertility Treatment Imaging Systems , by Region USD Million (2025-2030)
  • Table 149. Infertility Treatment Incubators , by Region USD Million (2025-2030)
  • Table 150. Infertility Treatment Sperm Analyzer Systems , by Region USD Million (2025-2030)
  • Table 151. Infertility Treatment Laser Systems , by Region USD Million (2025-2030)
  • Table 152. Infertility Treatment Micromanipulator Systems , by Region USD Million (2025-2030)
  • Table 153. Infertility Treatment Cryosystems , by Region USD Million (2025-2030)
  • Table 154. Infertility Treatment: by Procedure(USD Million)
  • Table 155. Infertility Treatment Assisted Reproductive Technology , by Region USD Million (2025-2030)
  • Table 156. Infertility Treatment Artificial Insemination , by Region USD Million (2025-2030)
  • Table 157. Infertility Treatment Fertility Surgery , by Region USD Million (2025-2030)
  • Table 158. Infertility Treatment Other Infertility Treatment Procedures , by Region USD Million (2025-2030)
  • Table 159. Infertility Treatment: by Patients(USD Million)
  • Table 160. Infertility Treatment Female , by Region USD Million (2025-2030)
  • Table 161. Infertility Treatment Male , by Region USD Million (2025-2030)
  • Table 162. South America Infertility Treatment, by Country USD Million (2025-2030)
  • Table 163. South America Infertility Treatment, by Application USD Million (2025-2030)
  • Table 164. South America Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 165. South America Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 166. South America Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 167. Brazil Infertility Treatment, by Application USD Million (2025-2030)
  • Table 168. Brazil Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 169. Brazil Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 170. Brazil Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 171. Argentina Infertility Treatment, by Application USD Million (2025-2030)
  • Table 172. Argentina Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 173. Argentina Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 174. Argentina Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 175. Rest of South America Infertility Treatment, by Application USD Million (2025-2030)
  • Table 176. Rest of South America Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 177. Rest of South America Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 178. Rest of South America Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 179. Asia Pacific Infertility Treatment, by Country USD Million (2025-2030)
  • Table 180. Asia Pacific Infertility Treatment, by Application USD Million (2025-2030)
  • Table 181. Asia Pacific Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 182. Asia Pacific Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 183. Asia Pacific Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 184. China Infertility Treatment, by Application USD Million (2025-2030)
  • Table 185. China Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 186. China Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 187. China Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 188. Japan Infertility Treatment, by Application USD Million (2025-2030)
  • Table 189. Japan Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 190. Japan Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 191. Japan Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 192. India Infertility Treatment, by Application USD Million (2025-2030)
  • Table 193. India Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 194. India Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 195. India Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 196. South Korea Infertility Treatment, by Application USD Million (2025-2030)
  • Table 197. South Korea Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 198. South Korea Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 199. South Korea Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 200. Taiwan Infertility Treatment, by Application USD Million (2025-2030)
  • Table 201. Taiwan Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 202. Taiwan Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 203. Taiwan Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 204. Australia Infertility Treatment, by Application USD Million (2025-2030)
  • Table 205. Australia Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 206. Australia Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 207. Australia Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Infertility Treatment, by Application USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 211. Rest of Asia-Pacific Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 212. Europe Infertility Treatment, by Country USD Million (2025-2030)
  • Table 213. Europe Infertility Treatment, by Application USD Million (2025-2030)
  • Table 214. Europe Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 215. Europe Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 216. Europe Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 217. Germany Infertility Treatment, by Application USD Million (2025-2030)
  • Table 218. Germany Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 219. Germany Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 220. Germany Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 221. France Infertility Treatment, by Application USD Million (2025-2030)
  • Table 222. France Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 223. France Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 224. France Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 225. Italy Infertility Treatment, by Application USD Million (2025-2030)
  • Table 226. Italy Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 227. Italy Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 228. Italy Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 229. United Kingdom Infertility Treatment, by Application USD Million (2025-2030)
  • Table 230. United Kingdom Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 231. United Kingdom Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 232. United Kingdom Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 233. Netherlands Infertility Treatment, by Application USD Million (2025-2030)
  • Table 234. Netherlands Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 235. Netherlands Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 236. Netherlands Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 237. Rest of Europe Infertility Treatment, by Application USD Million (2025-2030)
  • Table 238. Rest of Europe Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 239. Rest of Europe Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 240. Rest of Europe Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 241. MEA Infertility Treatment, by Country USD Million (2025-2030)
  • Table 242. MEA Infertility Treatment, by Application USD Million (2025-2030)
  • Table 243. MEA Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 244. MEA Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 245. MEA Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 246. Middle East Infertility Treatment, by Application USD Million (2025-2030)
  • Table 247. Middle East Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 248. Middle East Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 249. Middle East Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 250. Africa Infertility Treatment, by Application USD Million (2025-2030)
  • Table 251. Africa Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 252. Africa Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 253. Africa Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 254. North America Infertility Treatment, by Country USD Million (2025-2030)
  • Table 255. North America Infertility Treatment, by Application USD Million (2025-2030)
  • Table 256. North America Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 257. North America Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 258. North America Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 259. United States Infertility Treatment, by Application USD Million (2025-2030)
  • Table 260. United States Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 261. United States Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 262. United States Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 263. Canada Infertility Treatment, by Application USD Million (2025-2030)
  • Table 264. Canada Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 265. Canada Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 266. Canada Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 267. Mexico Infertility Treatment, by Application USD Million (2025-2030)
  • Table 268. Mexico Infertility Treatment, by Equipment USD Million (2025-2030)
  • Table 269. Mexico Infertility Treatment, by Procedure USD Million (2025-2030)
  • Table 270. Mexico Infertility Treatment, by Patients USD Million (2025-2030)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Infertility Treatment: by Application USD Million (2018-2023)
  • Figure 5. Global Infertility Treatment: by Equipment USD Million (2018-2023)
  • Figure 6. Global Infertility Treatment: by Procedure USD Million (2018-2023)
  • Figure 7. Global Infertility Treatment: by Patients USD Million (2018-2023)
  • Figure 8. South America Infertility Treatment Share (%), by Country
  • Figure 9. Asia Pacific Infertility Treatment Share (%), by Country
  • Figure 10. Europe Infertility Treatment Share (%), by Country
  • Figure 11. MEA Infertility Treatment Share (%), by Country
  • Figure 12. North America Infertility Treatment Share (%), by Country
  • Figure 13. Global Infertility Treatment share by Players 2023 (%)
  • Figure 14. Global Infertility Treatment share by Players (Top 3) 2023(%)
  • Figure 15. Global Infertility Treatment share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. The Cooper Companies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. The Cooper Companies Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Vitrolife AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 20. Vitrolife AB (Sweden) Revenue: by Geography 2023
  • Figure 21. Cook Group Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cook Group Incorporated (United States) Revenue: by Geography 2023
  • Figure 23. Esco Micro Pte. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 24. Esco Micro Pte. Ltd. (Singapore) Revenue: by Geography 2023
  • Figure 25. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Genea Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 28. Genea Limited (Australia) Revenue: by Geography 2023
  • Figure 29. Irvine Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 30. Irvine Scientific (United States) Revenue: by Geography 2023
  • Figure 31. The Baker Company, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 32. The Baker Company, Inc.(United States) Revenue: by Geography 2023
  • Figure 33. IVFtech ApS (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. IVFtech ApS (Denmark) Revenue: by Geography 2023
  • Figure 35. Kitazato (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Kitazato (Japan) Revenue: by Geography 2023
  • Figure 37. Global Infertility Treatment: by Application USD Million (2025-2030)
  • Figure 38. Global Infertility Treatment: by Equipment USD Million (2025-2030)
  • Figure 39. Global Infertility Treatment: by Procedure USD Million (2025-2030)
  • Figure 40. Global Infertility Treatment: by Patients USD Million (2025-2030)
  • Figure 41. South America Infertility Treatment Share (%), by Country
  • Figure 42. Asia Pacific Infertility Treatment Share (%), by Country
  • Figure 43. Europe Infertility Treatment Share (%), by Country
  • Figure 44. MEA Infertility Treatment Share (%), by Country
  • Figure 45. North America Infertility Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • The Cooper Companies Inc. (United States)
  • Vitrolife AB (Sweden)
  • Cook Group Incorporated (United States)
  • Esco Micro Pte. Ltd. (Singapore)
  • Thermo Fisher Scientific, Inc. (United States)
  • Genea Limited (Australia)
  • Irvine Scientific (United States)
  • The Baker Company, Inc.(United States)
  • IVFtech ApS (Denmark)
  • Kitazato (Japan)
Additional players considered in the study are as follows:
Rocket Medical Plc (United Kingdom) , IHMedical A/S (Denmark) , MedGyn Products, Inc. (United States) , ZEISS Group (Germany) , Hamilton Throne Ltd. (United States) , SoMATEX Medical Technologies GmbH (Germany)
Select User Access Type

Key Highlights of Report


Jan 2024 243 Pages 61 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Infertility Treatment Quantitative research analysis
Global Infertility Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as The Cooper Companies Inc. (United States), Vitrolife AB (Sweden), Cook Group Incorporated (United States), Esco Micro Pte. Ltd. (Singapore), Thermo Fisher Scientific, Inc. (United States), Genea Limited (Australia), Irvine Scientific (United States), The Baker Company, Inc.(United States), IVFtech ApS (Denmark) and Kitazato (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Infertility Treatment Market during projected period 2023-2030.
The Infertility Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Infertility Treatment Report?

Have a Query? Click Here

Other Related Reports

Pediatric Interventional Cardiology Comprehensive Study by Type (Congenital Heart Defect Closure Devices (Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Foramen Ovale (PFO) C...
$ 3750
Animal Stem Cell Therapy Comprehensive Study by Type (Dogs, Cats, Horses, Others), Application (Osteoarthritis, Injuries to bones, Joints, Tendons, Ligament, Spinal cord, Others), Sources (Embryonic ...
$ 3650
Neuropathy Pain Treatment Comprehensive Study by Type (Peripheral Neuropathy, Entrapment Neuropathy, Post Traumatic Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Phantom Limb Pain,...
$ 3750
Vitamin Deficiency Treatment Comprehensive Study by Type (Multivitamin Deficiency Treatment, Single Vitamin Deficiency Treatment), End Users (Adults, Kids), Route of Administration (Oral, Parenteral)...
$ 3650
Bronchitis Treatment Comprehensive Study by Type (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Drugs Class (Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Other), ...
$ 3450
Preterm Labor Treatment Comprehensive Study by Type (Devices, Cervical Cerclage, Vaginal Pessaries, Drug), Application (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes, Pharmacy), Distributi...
$ 3750